Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design

European Journal of Cardio-thoracic Surgery

Volumn 42, Issue 4, 2012, Pages

  Sündermann, Simon H ^a   Grünenfelder, Jürg ^a   Corti, Roberto ^a   Rastan, Ardawan J ^b   Linke, Axel ^b   Lange, Rüdiger ^c   Falk, Volkmar ^a   Bleiziffer, Sabine ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aortic valve disease; Minimally invasive surgery; Transapical aortic valve replacement

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

AGED; AORTA DISSECTION; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTOGRAPHY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLETE HEART BLOCK; CORONARY ARTERY OBSTRUCTION; EQUIPMENT DESIGN; FEASIBILITY STUDY; FEMALE; FLUOROSCOPY; GUIDE WIRE; HEART ATRIUM FIBRILLATION; HEART VALVE BIOPROSTHESIS; HUMAN; INVASIVE PROCEDURE; MALE; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE PERIOD; PRESSURE GRADIENT; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSLUMINAL VALVULOPLASTY; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; ENDOVASCULAR PROCEDURES; FEASIBILITY STUDIES; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; TREATMENT OUTCOME;

EID: 84873196477     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs389     Document Type: Article

References (9)

1. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk. J Am Coll Cardiol 2010;55:1080-90.
2. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010;122:62-9.
3. Kempfert J, Rastan AJ, Mohr FW, Walther T. A new self-expanding transcatheter aortic valve for transapical implantation-first in man implantation of the JenaValve™. Eur J Cardiothorac Surg 2011;40:761-3.
4. Kempfert J, Rastan AJ, Beyersdorf F, Schönburg M, Schuler G, Sorg S et al. Trans-apical aortic valve implantation using a new self-expandable bioprosthesis: initial outcomes. Eur J Cardiothorac Surg 2011;40:1114-9.
5. Lange R, Schreiber C, Götz W, Hettich I, Will A, Libera P et al. First successful transapical aortic valve implantation with the Corevalve Revalving system: a case report. Heart Surg Forum 2007;10:E478-9.
6. Falk V, Walther T, Schwammenthal E, Strauch J, Aicher D, Wahlers T et al. Transapical aortic valve implantation with a self-expanding anatomically oriented valve. Eur Heart J 2011;32:878-87.
7. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein P et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials. JACC 2011;57:253-69.
8. Walther T, Falk V, Kempfert J, Borger MA, Fassl J, Chu MW et al. Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J Cardiothorac Surg 2008;33:983-8.
9. Ewe SH, Delgado V, Ng AC, Antoni ML, van der Kley F, Marsan NA et al. Outcomes after transcatheter aortic valve implantation: transfemoral versus transapical approach. Ann Thorac Surg 2011;92:1244-51.